QNME · Quanome Technologies, Inc.

NasdaqIndustrialsAirlines, Airports & Air Services

Quanome Technologies Inc Operates In The Midstream Segment Of The Pharmaceutical Industrial Ecosystem, Operating Between Upstream Pharmaceutical Manufacturers And Downstream Medical End Customers. It Sources Products From Multiple Manufacturers And Suppliers, And Distribute Them To Hospitals, Pharmaceutical Distributors And Other Healthcare Providers. Its Principal Product Categories Include Infusion Products, Foods For Special Medical Purposes, And Specialty Pharmaceuticals. It Operates In One Reportable Segment Serves Its Customers By Providing Pharmaceutical Products In China. The Company Generates A Substantial Percentage Of Its Revenue From Selling Pharmaceutical Products On A Direct Basis.

IndustrialsNasdaqUSMid Float

$0.94

+58.2% latest move

Price & move as of the most recent catalyst (Oct 8) — not a live quote.

FLOAT

28.8M

FREE FLOAT %

84%

SHARES O/S

34.4M

MARKET CAP

$19.3M

EXCHANGE

Nasdaq

COUNTRY

QNME Catalyst History

Products and ContractsNew Enterprise DealOct 8, 2026 · 2:39pm ET

QNMEQuanome Technologies, Inc.

Be early on the next QNME spark.

Day Trader Sniper alerts you the instant a setup like this triggers.

How it works Download Free →

QNME · Quanome Technologies, Inc.

QNME Catalyst History

Quanome Technologies Secures First Enterprise Customer Agreement for AI Inference Services

Quanome Technologies Secures First Enterprise Customer Agreement for AI Inference Services

Quanome Technologies Announces $18.8 Million Infrastructure Purchase for AI Cloud Business XDT

Quanome Technologies Announces $18.8 Million Infrastructure Purchase for AI Cloud Business XDT

Quanome Technologies, Inc. Executes Purchase and Sale Agreement for 32 GPU Servers

Quanome Technologies, Inc. Executes Purchase and Sale Agreement for 32 GPU Servers